NCT02336035

Brief Summary

Eligible patients that sign an informed consent will be randomized to operation with volar locking plate or cast immobilization. Primary follow-up after 1 year.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

January 5, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 12, 2015

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

September 10, 2021

Status Verified

September 1, 2021

Enrollment Period

3.7 years

First QC Date

January 5, 2015

Last Update Submit

September 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quick disabilities of the arm, shoulder and hand; Quick-DASH

    Questionnaire

    1 year

Secondary Outcomes (9)

  • Quick DASH

    3 and 6 months; 2 and 5 years

  • Patient rated wrist evaluation (PRWE)

    3, 6 and 12 months; 2 and 5 years

  • Grip strength

    3, 6 and 12 months; 2 and 5 years

  • Range of motion

    3, 6 and 12 months; 2 and 5 years

  • Over all satisfaction

    6 weeks; 3, 6 and 12 months; 2 and 5 years

  • +4 more secondary outcomes

Study Arms (2)

Cast immobilization

NO INTERVENTION

Cast immobilization for 5 weeks from primary injury/reduction. Thereafter active exercise within the range of pain. Both groups will be followed after 3, 6 and 12 months, and after 2 and 5 years.

Operation

EXPERIMENTAL

Operation with a volar plate. Cast immobilization for 2 weeks after operation, thereafter active motion without weight for 4 weeks. 6 weeks after operation the patients are allowed active exercise within the range of pain. Both groups will be followed after 3, 6 and 12 months, and after 2 and 5 years.

Procedure: Volar plate

Interventions

Volar platePROCEDURE

Flexor carpi radialis (FCR)-approach. Standard surgical procedure with a volar locking plate

Also known as: Volar locking plate, VLP
Operation

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • AO/OTA class A- and C-fractures
  • Age \> 65 years
  • Unacceptable primary reduction or redislocation \< 20 days post-injury with at least one of the following findings:
  • dorsal angulation \> 10 degrees
  • radial shortening \> 3 mm
  • intraarticular step-off \> 2 mm
  • Ability to sign an informed consent
  • Ability to reconstruct the articular surface with a volar locking plate

You may not qualify if:

  • Volar angulated fractures and AO type B
  • Associated diseases contraindicating surgery
  • Mental impairment, nursery home patient
  • Earlier wrist injury
  • Pathological fractures
  • Open fractures (\>Gustilo-Anderson I) or damaged soft tissue
  • Drug abuse
  • Concomitant injuries that might affect outcome
  • Congenital anomaly of affected extremity
  • Median nerve compression that requires acute operation
  • Foreign language
  • Tourists

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University hospital

Oslo, 0586, Norway

Location

MeSH Terms

Conditions

Wrist Fractures

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Study Officials

  • Jan Erik Madsen, Professor

    University of Oslo

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 5, 2015

First Posted

January 12, 2015

Study Start

January 1, 2015

Primary Completion

September 1, 2018

Study Completion

September 1, 2022

Last Updated

September 10, 2021

Record last verified: 2021-09

Locations